HAVCR2 and glioma: The study by Shen and colleagues demonstrated similar results, showing that NK cells from glioma patients (13 out of 20 were glioblastoma patients), had a significantly higher percentage of TIM-3 positivity compared to NK cells from healthy controls [102].